IP Library Granted Patent US 9,688,690
Granted Patent B2
US 9,688,690 · App. 14/820,725 · Granted Jun 27, 2017

Pyrimidine compounds and pyrimido indole compounds and methods of use

Inventor: Aleem Gangjee (Allison Park, PA)
Assignee: Duquesne University of the Holy Ghost
C07D495/04A61K31/343A61K31/4709A61K31/505C07D239/48C07D403/02C07D405/02C07D487/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,688,690
App. No.
14/820,725
Granted
Jun 27, 2017
Kind
B2
Abstract

The present invention discloses a compound comprising the formula: wherein R is hydrogen or an alkyl group having from one to ten carbon atoms, or a compound of the formula wherein the S is replaced by CH 2 , and optionally comprising a pharmaceutically acceptable salt, hydrate, or solvate thereof. A method of treating a patient having cancer or a disease comprising administering to a patient an effective amount of the compound or pharmaceutically acceptable salt, hydrate, or solvate thereof.

Claims (9)

1. A compound of the formula:

and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.

2. A compound of the formula:

wherein R is an alkyl group having from one to ten carbon atoms, NH 2 , I, or CN, and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.

3. A pharmaceutical composition comprising a therapeutically effective amount of a compound of the formula:

and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.

4. A pharmaceutical composition comprising a therapeutically effective amount of a compound of the formula:

wherein R is an alkyl group having from one to ten carbon atoms, NH 2 , I, or CN, and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.

5. The pharmaceutical composition of claims 3 or 4 comprising at least one pharmaceutical carrier.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 6, 2016
From: GANGJEE, ALEEM
To: DUQUESNE UNIVERSITY OF THE HOLY SPIRIT
Reel/Frame 038487/0020 →
Continuity (2)
Provisional Application 62035234 · Aug 8, 2014
Related Publication 20160039840A1 · Feb 11, 2016